Literature DB >> 21686709

A case report of a salivary amylase secreting plasmacytoma in a patient with multiple myeloma.

Serena L Harborne1, Rachael Curley, David W Bullimore, Dominic Chan-Lam, Jean-Pierre Ng, Philip T McAndrew.   

Abstract

A 70-year-old lady with a past medical history of light chain myeloma, chronic renal failure and a left breast plasmacytoma treated with radiotherapy was admitted for drainage of a subsequent left pleural effusion. She was given high dose steroids for her myeloma, following which she developed abdominal pain suspicious of pancreatitis. Results revealed a raised serum amylase of 5117, a modified Glasgow score of 3 and normal calcium levels. The working diagnosis was drug-induced pancreatitis and steroids were stopped. She remained well and her abdominal pain settled, but amylase remained markedly raised despite no findings of pancreatic pathology. A subsequent isoenzyme test on the amylase found it to be salivary amylase secreted from the plasmacytoma. The patient had her steroid therapy restarted and was allowed to be discharged from hospital.

Entities:  

Year:  2009        PMID: 21686709      PMCID: PMC3029604          DOI: 10.1136/bcr.08.2008.0639

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Bilateral plasmacytoma of the breast: a case report.

Authors:  Rachel F Brem; Geraldine Revelon; Shawna C Willey; Olga M B Gatewood; Martha A Zeiger
Journal:  Breast J       Date:  2002 Nov-Dec       Impact factor: 2.431

2.  Hyperammonemic encephalopathy in multiple myeloma.

Authors:  Victoria Furer; Judith Heyd
Journal:  Isr Med Assoc J       Date:  2007-07       Impact factor: 0.892

3.  Paraneoplastic hyperamylasaemia in association with multiple myeloma.

Authors:  Jose M Calvo-Villas; Iván Alvarez; Elena Carretera; Juan Espinosa; Francisco Sicilia
Journal:  Acta Haematol       Date:  2007       Impact factor: 2.195

4.  [Ectopic production of amylase by a non-producing type of multiple myeloma].

Authors:  H Wada; T Ohtsuki; T Sugihara; K Ata; M Hashimoto; O Yamada; Y Yawata; T Manabe; K Miyamoto
Journal:  Rinsho Ketsueki       Date:  1990-07

5.  [Acquired amylase production induced by radiotherapy in a myeloma patient].

Authors:  T Yamakawa; H Nagoshi; A Takahashi; R Fukumura; S Takahashi; M Nomura; H Isobe; K Ide; T Ayabe; S Shimizu
Journal:  Rinsho Ketsueki       Date:  1995-10

Review 6.  Hyperamylasaemia and multiple myeloma.

Authors:  Colleen M Ross; Manjit S Devgun; Ian R Gunn
Journal:  Ann Clin Biochem       Date:  2002-11       Impact factor: 2.057

  6 in total
  1 in total

1.  Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.

Authors:  Shohei Mizuno; Ichiro Hanamura; Akinobu Ota; Sivasundaram Karnan; Tomoko Narita; Masaki Ri; Motonori Mizutani; Mineaki Goto; Mayuko Gotou; Norikazu Tsunekawa; Masato Shikami; Shinsuke Iida; Yoshitaka Hosokawa; Hiroshi Miwa; Ryuzo Ueda; Masakazu Nitta; Akiyoshi Takami
Journal:  Int J Hematol       Date:  2015-09-04       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.